From Serendipity to Pilot Study and Then Pivotal Trial: Bimatoprost Topical for Eyelash Growth
Dr. Cohen has been a consultant and clinical trial investigator for Allergan (including related to Latisse).
See the rest here:
From Serendipity to Pilot Study and Then Pivotal Trial: Bimatoprost Topical for Eyelash Growth
FDA Advisory Committee Unanimously Recommends Approval of Latisse (Bimatoprost Solution 0.03%) as a Treatment for Hypotrichosis of Eyelashes
IRVINE, Calif.–(BUSINESS WIRE)–Dec 5, 2008 – Allergan, Inc. today announced the U.S.
